Man Group’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.47M | Buy |
78,168
+63,891
| +448% | +$3.31M | 0.01% | 1088 |
|
|
2026
Q1 | $725K | Sell |
14,277
-504,022
| -97% | -$23.5M | ﹤0.01% | 1940 |
|
|
2025
Q4 | $15.3M | Sell |
518,299
-673,544
| -57% | -$18.3M | 0.03% | 618 |
|
|
2025
Q3 | $30.8M | Buy |
1,191,843
+1,043,871
| +705% | +$29.1M | 0.05% | 380 |
|
|
2025
Q2 | $4.08M | Buy |
147,972
+79,606
| +116% | +$2.1M | 0.01% | 1136 |
|
|
2025
Q1 | $1.94M | Buy |
+68,366
| New | +$2.43M | ﹤0.01% | 1371 |
|
|
2024
Q4 | – | Sell |
-228,851
| Closed | -$15.3M | – | 2114 |
|
|
2024
Q3 | $15.3M | Sell |
228,851
-26,884
| -11% | -$2.47M | 0.04% | 550 |
|
|
2024
Q2 | $30.4M | Buy |
255,735
+232,673
| +1,009% | +$29.4M | 0.08% | 295 |
|
|
2024
Q1 | $2.46M | Sell |
23,062
-3,161
| -12% | -$319K | 0.01% | 1229 |
|
|
2023
Q4 | $2.61M | Buy |
+26,223
| New | +$2.21M | 0.01% | 1194 |
|
|
2023
Q3 | – | Sell |
-91,091
| Closed | -$10.2M | – | 689 |
|
|
2023
Q2 | $11.1M | Buy |
+91,091
| New | +$12.2M | 0.03% | 590 |
|
|
2023
Q1 | – | Sell |
-42,377
| Closed | -$6.99M | – | 433 |
|
|
2022
Q4 | $7.61M | Sell |
42,377
-214,401
| -83% | -$35.1M | 0.03% | 679 |
|
|
2022
Q3 | $30.4M | Buy |
+256,778
| New | +$39M | 0.14% | 176 |
|
|
2022
Q2 | – | Sell |
-46,217
| Closed | -$6.61M | – | 279 |
|
|
2022
Q1 | $7.96M | Sell |
46,217
-9,217
| -17% | -$1.55M | 0.03% | 704 |
|
|
2021
Q4 | $14.1M | Buy |
55,434
+36,236
| +189% | +$10.6M | 0.05% | 476 |
|
|
2021
Q3 | $7.39M | Buy |
19,198
+13,831
| +258% | +$5.1M | 0.03% | 685 |
|
|
2021
Q2 | $1.26M | Sell |
5,367
-2,417
| -31% | -$432K | ﹤0.01% | 1340 |
|
|
2021
Q1 | $1.02M | Sell |
7,784
-23,225
| -75% | -$3.37M | ﹤0.01% | 1285 |
|
|
2020
Q4 | $3.24M | Sell |
31,009
-9,934
| -24% | -$1M | 0.01% | 1011 |
|
|
2020
Q3 | $2.9M | Sell |
40,943
-48,970
| -54% | -$3.41M | 0.01% | 1058 |
|
|
2020
Q2 | $5.77M | Buy |
89,913
+61,638
| +218% | +$3.38M | 0.03% | 600 |
|
|
2020
Q1 | $847K | Sell |
28,275
-28,925
| -51% | -$665K | 0.01% | 1151 |
|
|
2019
Q4 | $1.12M | Buy |
+57,200
| New | +$1.01M | ﹤0.01% | 1481 |
|
|
2019
Q2 | – | Sell |
-96,104
| Closed | -$1.96M | – | 1957 |
|
|
2019
Q1 | $1.96M | Sell |
96,104
-219,197
| -70% | -$4.07M | 0.01% | 1347 |
|
|
2018
Q4 | $4.81M | Buy |
+315,301
| New | +$5.18M | 0.02% | 783 |
|
Other funds holding MRNA
TP
Man Group's MRNA Position: Q2 2026 in Review
Man Group increased its Moderna (MRNA) stake by 448% in Q2 2026, buying an estimated $3.31M and bringing the position to 78,168 shares worth $5.47M. The position accounts for 0.01% of the portfolio, ranked #1088.
Man Group first reported a position in MRNA in Q4 2018 and has held it in 25 quarters since. The position peaked at $30.8M in Q3 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Man Group held 78,168 shares of Moderna worth $5.47M as of Q2 2026.
- Man Group bought 63,891 Moderna shares in Q2 2026, an estimated $3.31M.
- Moderna made up 0.01% of Man Group's portfolio in Q2 2026, its #1088 holding.
- Man Group first reported a position in Moderna in Q4 2018 and has held it in 25 quarters since.
- Man Group's Moderna position peaked at $30.8M in Q3 2025.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.